Therapeutic Asset Ratings
208 results matching 1 filter
133,990 assets · 8,802 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
DEXAMETHASONE
Solid Tumors
Hellenic Society of Hematology
P3
BB
(66)
FILGRASTIM
Solid Tumors
Ankara Etlik City Hospital
P2
BB
(66)
Carboplatin
Solid Tumors
Bristol-Myers Squibb
P3
BB
(64)
Ribociclib
Solid Tumors
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
P4
B
(63)
CIS-DIAMMINEDICHLOROPLATINUM II
Solid Tumors
Mabwell (Shanghai) Bioscience Co., Ltd.
P3
B
(62)
Hycamtin
Solid Tumors
Actuate Therapeutics Inc.
P3
B
(62)
Inno-206
Solid Tumors
The First Affiliated Hospital of Soochow University
P3
B
(62)
Irinotecan
Solid Tumors
Mirati Therapeutics Inc.
P3
B
(62)
PREDNISONE TABLETS
Solid Tumors
The First Affiliated Hospital of Soochow University
P3
B
(62)
ETOPOSIDE
Solid Tumors
Shanghai Pulmonary Hospital, Shanghai, China
P2
B
(62)
gsk1120212
Solid Tumors
Cancer Research UK
P4
B
(61)
LIDOCAINE
Solid Tumors
Mabwell (Shanghai) Bioscience Co., Ltd.
P4
B
(61)
Bortezomib
Solid Tumors
Hellenic Society of Hematology
P3
B
(61)
Carfilzomib
Solid Tumors
Fondazione EMN Italy Onlus
P3
B
(60)
Panobinostat
Solid Tumors
National Cancer Institute (NCI)
P3
B
(60)
Palbociclib
Solid Tumors
Tianjin Medical University Second Hospital
P2
B
(60)
FULVESTRANT
Solid Tumors
Terremoto Biosciences Inc.
P2/3
B
(60)
Temsirolimus
Solid Tumors
Miller Children's & Women's Hospital Long Beach
P1/2
B
(60)
su011248
Solid Tumors
3D Medicines (Sichuan) Co., Ltd.
P3
B
(59)
Talzenna
Solid Tumors
Pfizer
P3
B
(59)
Veliparib
Solid Tumors
National Cancer Institute (NCI)
P1/2
B
(59)
gw786034
Solid Tumors
Tianjin Medical University Second Hospital
P2
B
(58)
Bms-907351
Solid Tumors
Arcus Biosciences, Inc.
P2
B
(57)
Cytosin-Arabinosid
Solid Tumors
Kura Oncology, Inc.
P2
B
(57)
Azacitidine
Solid Tumors
National University Hospital, Singapore
P1/2
B
(57)
Showing 1 to 25 of 208 assets
Previous
Page 1 of 9
Next